TY - JOUR
T1 - Effect of okadaic acid on human basophil secretion
AU - Botana, Luis M.
AU - MacGlashan, Donald W.
N1 - Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 1993/6/9
Y1 - 1993/6/9
N2 - We examined the effects of a phosphatase inhibitor, okadaic acid, on mediator secretion from human basophils. These cells are known to respond to a number of stimuli that appear to utilize distinct biochemical pathways converging on mediator release. Okadaic acid was found to inhibit IgE-mediated release (histamine release inhibited 80 ± 12% and leukotriene release inhibited 100% following a 10-min preincubation with okadaic acid and stimulation with an optimal concentration of anti-IgE antibody) at a concentration of 1 μM. The concentration-response curve to okadaic acid was steep, with 0.1 μM yielding only 20 ± 10% inhibition of either mediator. Secretion following stimulation with the univalent stimulus, fMet-Leu-Phe peptide, was not inhibited by okadaic acid. Unlike cAMP-active agents that inhibit cytosolic Ca2+ elevations following IgE-mediated stimulation, the increased state of cellular protein phosphorylation, which presumably results from treatment with 1 μM okadaic acid, had no effect on the elevations in free cytosolic Ca2+ that follow stimulation with anti-IgE antibody of fMet peptide.
AB - We examined the effects of a phosphatase inhibitor, okadaic acid, on mediator secretion from human basophils. These cells are known to respond to a number of stimuli that appear to utilize distinct biochemical pathways converging on mediator release. Okadaic acid was found to inhibit IgE-mediated release (histamine release inhibited 80 ± 12% and leukotriene release inhibited 100% following a 10-min preincubation with okadaic acid and stimulation with an optimal concentration of anti-IgE antibody) at a concentration of 1 μM. The concentration-response curve to okadaic acid was steep, with 0.1 μM yielding only 20 ± 10% inhibition of either mediator. Secretion following stimulation with the univalent stimulus, fMet-Leu-Phe peptide, was not inhibited by okadaic acid. Unlike cAMP-active agents that inhibit cytosolic Ca2+ elevations following IgE-mediated stimulation, the increased state of cellular protein phosphorylation, which presumably results from treatment with 1 μM okadaic acid, had no effect on the elevations in free cytosolic Ca2+ that follow stimulation with anti-IgE antibody of fMet peptide.
UR - http://www.scopus.com/inward/record.url?scp=0027162666&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027162666&partnerID=8YFLogxK
U2 - 10.1016/0006-2952(93)90204-A
DO - 10.1016/0006-2952(93)90204-A
M3 - Article
C2 - 8517872
AN - SCOPUS:0027162666
SN - 0006-2952
VL - 45
SP - 2311
EP - 2315
JO - Biochemical Pharmacology
JF - Biochemical Pharmacology
IS - 11
ER -